It has also been demonstrated that ER+ BC cells treated with tamoxifen, results in decreased phosphorylation of STAT3 at serine 727, suggesting an association between tamoxifen sensitivity and decreased STAT3 transcriptional activity (335). This evidence concerns the gene STAT3 and breast cancer.